PRVL Financial Facts

See Full Income Statement

See Full Balance Sheet

Prevail Therapeutics (PRVL) Earnings

  |   Expand Research on PRVL
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -3.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -4.5% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/11/20 Q220 -$0.66-$0.59 -$0.07N/AN/A N/A Details